Osteoporosis and Cardiovascular Disease Care in Systemic Lupus Erythematosus According to New Quality Indicators

被引:20
作者
Demas, Kristina L. [2 ]
Keenan, Brendan T. [1 ]
Solomon, Daniel H. [1 ]
Yazdany, Jinoos [3 ]
Costenbader, Karen H. [1 ]
机构
[1] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[2] George Washington Sch Med, Washington, DC USA
[3] UCSF, Div Rheumatol, San Francisco, CA USA
关键词
systemic lupus erythematosus; quality indicator; osteoporosis; cardiovascular disease; bone mineral density; screening; cholesterol; blood pressure; management; risk factor; calcium and vitamin D; ACCELERATED ATHEROSCLEROSIS; RISK-FACTORS; REVISED CRITERIA; CORTICOSTEROIDS; CLASSIFICATION; PREVENTION; GUIDELINES; RATES;
D O I
10.1016/j.semarthrit.2010.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Quality indicators (QIs) for the assessment of care of patients with systemic lupus erythematosus (SLE) have been proposed. We evaluated care according to these proposed QIs for osteoporosis and cardiovascular disease (CVD) in patients with SLE in our rheumatology practice. Methods: We selected 200 patients with SLE according to American College of Rheumatology Criteria and >= 2 visits to our practice in 2007 to 2008. We performed a structured medical record review and collected demographics, SLE and past medical history, medications, laboratories and data concerning osteoporosis, and CVD management. We employed univariable analyses and multivariable regression analyses to test for factors associated with care meeting the proposed QIs. Results: Ninety-four percent of patients were female and 64% were white. Mean age was 46.3 years and mean lupus duration was 15.3 years. Twenty-nine percent were taking >= 7.5 mg prednisone per day for >= 3 months. The proportions of patients for whom care met the proposed QIs were as follows: 59% for bone mineral density testing, 62% for calcium and vitamin D supplementation, and 86% for antiresorptive or anabolic osteoporosis medications. Only 3% had 5 cardiac risk factors assessed within the year and 26% had 4 cardiac risk factors assessed annually. Smoking, fasting lipid panels, and diabetes mellitus were rarely assessed annually. Having a primary care physician within our health care network increased care meeting QIs. Conclusions: Care according to newly proposed QIs for osteoporosis and CVD was suboptimal in our academic center. To standardize and improve care of patients with SLE, we suggest specific changes to the proposed QIs. (C) 2010 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 40:193-200
引用
收藏
页码:193 / 200
页数:8
相关论文
共 50 条
[41]   Epidemiology of cardiovascular disease in systemic lupus erythematosus [J].
Aranow, C ;
Ginzler, EM .
LUPUS, 2000, 9 (03) :166-169
[42]   Quality of care predicts outcome in systemic lupus erythematosus: a cross-sectional analysis of a German long-term study (LuLa cohort) [J].
Kernder, A. ;
Richter, J. G. ;
Fischer-Betz, R. ;
Winkler-Rohlfing, B. ;
Brinks, R. ;
Schneider, M. ;
Chehab, G. .
LUPUS, 2020, 29 (02) :136-143
[43]   Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus [J].
Hatano, Mika ;
Yajima, Nobuyuki ;
Yanai, Ryo ;
Ishii, Sho ;
Tsujimoto, Yasushi ;
Azuma, Teruhisa ;
Atsumi, Tatsuya ;
Kaneko, Yuko ;
Kameda, Hideto ;
Kuwana, Masataka ;
Tanaka, Yoshiya ;
Nakagawa, Shiori ;
Nakajima, Ayako ;
Hiramatsu, Yuri ;
Fujita, Daisuke ;
Miyamae, Takako ;
Murashima, Atsuko .
MODERN RHEUMATOLOGY, 2024, 34 (06) :1170-1177
[44]   Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus [J].
Bultink, Irene E. M. .
CALCIFIED TISSUE INTERNATIONAL, 2018, 102 (05) :575-591
[45]   Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients [J].
Mercurio, Valentina ;
Lobasso, Antonio ;
Barbieri, Letizia ;
Parrella, Paolo ;
Ciervo, Deasy ;
Liccardo, Bianca ;
Bonaduce, Domenico ;
Tocchetti, Carlo G. ;
De Paulis, Amato ;
Rossi, Francesca W. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
[46]   Annexin A5 in cardiovascular disease and systemic lupus erythematosus [J].
Cederholm, A ;
Frostegård, J .
IMMUNOBIOLOGY, 2005, 210 (10) :761-768
[47]   Cardiovascular disease and serum defensin levels in systemic lupus erythematosus [J].
Vordenbaeumen, S. ;
Sander, O. ;
Bleck, E. ;
Schneider, M. ;
Fischer-Betz, R. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) :364-370
[48]   Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus [J].
Zinglersen, Amanda Hempel ;
Iversen, Katrine Kjaer ;
Leffers, Henrik Christian Bidstrup ;
Laugesen, Esben ;
Fleischer, Jesper ;
Jacobsen, Soren .
LUPUS SCIENCE & MEDICINE, 2021, 8 (01)
[49]   Systemic Lupus Erythematosus: Primary Care Approach to Diagnosis and Management [J].
Nguyet-Cam Vu Lam ;
Ghetu, Maria V. ;
Bieniek, Marzena L. .
AMERICAN FAMILY PHYSICIAN, 2016, 94 (04) :284-294
[50]   Association of Changes in Relevant Indicators With Cardiovascular Disease and Osteoporosis in Perimenopausal and Postmenopausal Women [J].
Luo, Xiaoyan ;
Zhang, Jun ;
Guo, Yichuan ;
Xu, Liangzhi .
FOOD SCIENCE & NUTRITION, 2024, :10296-10305